While its safety profile was consistently favorable, the largest Phase IIb trial failed to show statistical significance for weight loss, and commercial development was halted in 2007.[2] Despite this, interest in AOD-9604 has continued in the compounding pharmacy and integrative medicine space, particularly given its safety data, its lack of IGF-1 stimulation, and emerging research around joint health
For best results, peptide therapy should be paired with consistent sleep, proper dosing, adequate protein intake, reduced alcohol consumption, regular lab monitoring, quality-sourced peptides, and effective stress management
Common OTC medications such as acetaminophen (Tylenol ) has been shown to deplete glutathione , especially in your liver
In addition, it has been difficult to compare the effects of l- and d-carnitine supplementation, because it has not been possible to eliminate the background of endogenous l-carnitine in vivo